Biomarker Summit 2017
March 20 - 22, 2017 - San Diego CA USGTCbio
infogtcbio@gtcbio.com
Phone:6262566405
Dear Colleague, The Biomarker Summit 2017, to be held on March 20-22, 2017 in San Diego, CA at the Hilton San Diego Resort & Spa, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization. A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in four major therapeutic areas, formally organized in the following tracks: General Session: Plenary Keynote Session Big Data Analytics & Bioinformatics for Biomarkers Development Emerging Technologies in Biomarker Development Overcoming Challenges of Clinical Validation & Translation Panel Discussion: Companion Diagnostics Development & Partnering Strategies Overcoming Commercialization Challenges in Biomarker Development -Regulatory & Reimbursement Trends in Biomarker Development -Current Landscape of Biomarkers IP & Future Trends 10th Oncology Biomarkers Circulating Tumor Cells & Microvesicles Liquid Biopsy: Circulating DNA & MicroRNA Immuno-oncology Biomarkers Novel Technologies in Oncology Biomarkers 6th Neurological Biomarkers Imaging Approaches in CNS Drug Discovery & Development CSF & Blood Based Biomarker Approaches Monitoring Progression in Neurodegenerative Disorders Novel Technologies in Neurological Biomarkers 6th Inflammatory & Immunological Biomarkers Biomarkers of Early Progressive Inflammatory & Immunological Diseases Biomarkers & Surrogate Endpoints for Clinical Trials in Inflammatory Diseases Microbiomes in Immune Modulation & Inflammatory Diseases Inflammatory Biomarkers in Respiratory Diseases Cardiovascular Biomarkers Biomarker R&D in the Cardiovascular Space Heart Failure & Acute Coronary Syndromes Metabolic Syndrome & Cardiovascular Risk Novel Technologies in Cardiovascular Biomarkers